BK vs TERN · P/E 17, rev $20.08B vs $6.12B cap
The Bank of New York Mellon Corporation (BK) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
BK currently screens at market cap $94.14B and trailing P/E 17.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the BK and TERN stock pages for the full models.
Not investment advice.